Specialties
Reports that name this provider
- Stem Cell Legality in Brazil
- Part of Fiocruz/Butantan partnership for domestic CAR-T cell manufacturing and development. Estimated cost USD 35,000 per dose versus USD 500,000 for imported therapies. First publicly funded clinical trial launched in 2024.
- Stem Cell Therapy Quality in Brazil
- Nutera-SP facility with GMP-certified clean rooms, media preparation rooms, quality control laboratories, and cryogenic storage; part of São Paulo's advanced therapies program